Adalimumab
Sold as Humira. Every FDA application for this active ingredient.
- First approved: Dec 31, 2002
- Applications: 1
- New uses approved: 24
- Complete response letters: 0
Applications
NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Dec 31, 2002 | HumiraBLA 125057 · New molecular entity | Abbvie Inc | 60 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Drugs@FDA